<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cure - Founder Stories</title>
    <link>https://wewillcure.com/insights/founder-stories</link>
    <description>Latest content from Cure in Founder Stories</description>
    <language>en</language>
    <lastBuildDate>Fri, 17 Apr 2026 08:51:28 GMT</lastBuildDate>
    <atom:link href="https://wewillcure.com/insights/founder-stories/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-oriana-zinani-phd</guid>
      <title><![CDATA[Cure Member Spotlight: Oriana Zinani, PhD]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-oriana-zinani-phd</link>
      <description><![CDATA[A Q&A with Oriana Zinani, PhD, Co-Founder and CEO of Applied PharmacoDynamics, on the science behind APD’s lead program for cocaine use disorder and what it takes to advance a first-in-class therapy in an area with enormous unmet need.
]]></description>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/ms3FWN4EGdQJ6aMKOzTo2/f7e04c7f01ab39318c9cc20bfb92b225/Cure_MSL_hero_article_Oriana_Zinani.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-matt-lewis</guid>
      <title><![CDATA[Cure Member Spotlight: Matt Lewis]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-matt-lewis</link>
      <description><![CDATA[A Q&A with Matt Lewis, CEO of Transformental, on why most AI transformations fail for human reasons, how healthcare organizations build “brain capital,” and what it takes to introduce AI responsibly in high-stakes environments.]]></description>
      <pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5nFnKlPMd5bVp1ivy0NpEM/a4b324b41a7afdaafc8441150c6cf890/Cure_MSL_hero_article_Matt_Lewis.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/regulatory-and-clinical-strategy/founder-stories/key-differences-between-building-healthcare-company-in-us-vs-europe</guid>
      <title><![CDATA[The Key Differences Between Building a Healthcare Company in the US vs Europe]]></title>
      <link>https://wewillcure.com/insights/regulatory-and-clinical-strategy/founder-stories/key-differences-between-building-healthcare-company-in-us-vs-europe</link>
      <description><![CDATA[Lessons from Wandercraft CEO Matthieu Masselin on how risk, reimbursement, and regulation fundamentally change when scaling a healthcare company across Europe and the US.]]></description>
      <pubDate>Fri, 06 Feb 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7AlsyHFQsNUEBulBTzNU85/c2575a952fcf9a4dec8169ba938094f6/C2C-_Wanderkraft-_Scaling_Medtech_Globally.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-karolyn-chamberlin</guid>
      <title><![CDATA[Cure Member Spotlight: Karolyn Chamberlin]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-karolyn-chamberlin</link>
      <description><![CDATA[A Q&A with Karolyn Chamberlin, COO of Rarecells, on the science behind ISET, why whole circulating tumor cells matter for early cancer detection, and the challenge of translating decades of academic research into clinical impact.]]></description>
      <pubDate>Fri, 30 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/UCn561idqZHgOpM6dXnO3/7e927c875e65ec9a0fd4f3a827a8c57c/Cure_MSL_hero_article_karolyn_chamberlin_rarecells.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/founder-stories/chemistry-needs-a-reset-excelsior-small-molecule-discovery</guid>
      <title><![CDATA[“Chemistry Needs a Reset”: Inside Excelsior’s Plan to Rebuild Small-Molecule Discovery]]></title>
      <link>https://wewillcure.com/insights/founder-stories/chemistry-needs-a-reset-excelsior-small-molecule-discovery</link>
      <description><![CDATA[In a Q&A with Cure, Excelsior's CEO Mike Foley explains why small-molecule chemistry has become a bottleneck, and how the company is rebuilding it for automation, AI, and domestic drug manufacturing.]]></description>
      <pubDate>Tue, 27 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/J4q2CeD8Pah3k0tZzww2h/8044d19f4a19cc39c03fb73e367d7254/thumbnail_michael_foley_1200x675.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/founder-stories/entrepreneurship/storytelling-gives-healthcare-companies-an-edge-heres-how-to-use-it-well</guid>
      <title><![CDATA[Storytelling Gives Healthcare Companies an Edge—Here's How to Use It Well]]></title>
      <link>https://wewillcure.com/insights/founder-stories/entrepreneurship/storytelling-gives-healthcare-companies-an-edge-heres-how-to-use-it-well</link>
      <description><![CDATA[Anne Fulenwider, co-founder and co-CEO of Alloy Helath, on why clear, jargon-free storytelling helps healthcare companies earn trust, traction, and scale. ]]></description>
      <pubDate>Tue, 20 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4yzRMH9SC4fXto8vN2aQU/44314a12ba57f85689177a403656360d/thumbnail_C2C_anne_fulenwider_compelling_narrative.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/founder-stories/entrepreneurship/how-great-biotech-companies-decide-which-diseases-to-take-on-mathai-mammen</guid>
      <title><![CDATA[How Great Biotech Companies Decide Which Diseases to Take On]]></title>
      <link>https://wewillcure.com/insights/founder-stories/entrepreneurship/how-great-biotech-companies-decide-which-diseases-to-take-on-mathai-mammen</link>
      <description><![CDATA[Mathai Mammen, MD, Chairman, CEO, and President of Parabilis Medicines, shares how great biotech founders decide which diseases are worth pursuing, and why problem selection shapes everything that follows.]]></description>
      <pubDate>Tue, 13 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/g8rk2NwEvNrakXJqdP2Af/93d886640779ffafc02ea8a2659e2544/C2C_thumbnail_mathai_mammen_ver02_16x9.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-gilead-kedem-md</guid>
      <title><![CDATA[Cure Member Spotlight: Gilead Kedem, MD]]></title>
      <link>https://wewillcure.com/insights/cure-member-spotlight/founder-stories/cure-member-spotlight-gilead-kedem-md</link>
      <description><![CDATA[A Q&A with PolyCypher Health CEO Gilead Kedem, MD, on predicting chronic disease risk, rethinking polygenic scoring, and building preventive genomics for real-world care.]]></description>
      <pubDate>Fri, 09 Jan 2026 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1HowXNjLFuugLrGa9FCwmc/d37f0ffb06c60ebf4722863fb222751e/Cure_MSL_hero_article_gilead_kedem_polycypher.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/biocurie-wins-2025-king-faisal-and-davos-of-healthcare-innovation-challenge</guid>
      <title><![CDATA[BioCurie Wins 2025 King Faisal & Davos of Healthcare Innovation Challenge ]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/biocurie-wins-2025-king-faisal-and-davos-of-healthcare-innovation-challenge</link>
      <description><![CDATA[Cell and gene therapies (CGTs) contain hold transformative potential for  patients with rare diseases, yet their high manufacturing costs keep them out of reach  for the most, a problem that BioCurie is working to solve.]]></description>
      <pubDate>Tue, 09 Sep 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6KcH2nAxRul7aljnzBHmBq/0cdaf927b8c384de2b48e09c4b30bd9e/EDT-2025-2905_HIN_WINNER.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/meet-the-five-finalists-in-the-king-faisal-and-davos-of-healthcare</guid>
      <title><![CDATA[Meet the Five Finalists in the King Faisal & Davos of Healthcare Innovation Challenge ]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/meet-the-five-finalists-in-the-king-faisal-and-davos-of-healthcare</link>
      <description><![CDATA[Five finalists from around the globe are pitching their transformative healthcare technologies, which span personalized cancer therapies, postpartum depression diagnostics, AI-driven cell and gene therapy manufacturing, hospital workflow systems, and next-generation gene editing.]]></description>
      <pubDate>Mon, 08 Sep 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6JrOInan5ksm3uf7LgxjCm/60805ae990c3cd080e91bb853b7f97e9/C3_Davos_of_healthcare_Summit.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/therapeutics/founder-stories/buckle-therapeutics-reimagines-naloxone-delivery-for-opioid-overdoses</guid>
      <title><![CDATA[Buckle Therapeutics Reimagines Naloxone Delivery for Opioid Overdoses]]></title>
      <link>https://wewillcure.com/insights/therapeutics/founder-stories/buckle-therapeutics-reimagines-naloxone-delivery-for-opioid-overdoses</link>
      <description><![CDATA[Buckle Therapeutics, a Cure Collaboration Residency company, is pioneering a buccal delivery system that applies naloxone to the inside of the cheek, simplifying delivery and overcoming the limits of nasal sprays, while unlocking new opportunities for quick-acting drugs.]]></description>
      <pubDate>Thu, 04 Sep 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3oxrkPYB5Qu3VsD6Pjt7nn/621f59df943624c5dfe32ee6c9b8fcfc/EDT_2025-1936_HIDI.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/how-a-missed-cancer-diagnosis-led-founder-to-build-ai-platform-for</guid>
      <title><![CDATA[How Missed Cancer Diagnosis Led Founder to Build AI Platform for Patients]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/how-a-missed-cancer-diagnosis-led-founder-to-build-ai-platform-for</link>
      <description><![CDATA[CureWise founder Steve Brown turned his own cancer scare into a platform for patients seeking more precise answers]]></description>
      <pubDate>Mon, 18 Aug 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1t2Q413he7NMgTIqXmR83F/07c31f84a6c9b56fe94974949d75a74f/Steve_Brown_action_16x9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/entrepreneurship/monica-cepaks-playbook-for-scaling-wisp-as-a-brand-women-actually-trust</guid>
      <title><![CDATA[Monica Cepak’s Playbook for Scaling Wisp as a Brand Women Actually Trust]]></title>
      <link>https://wewillcure.com/insights/womens-health/entrepreneurship/monica-cepaks-playbook-for-scaling-wisp-as-a-brand-women-actually-trust</link>
      <description><![CDATA[Monica Cepak is redefining what it means to lead in healthcare. She’s transforming Wisp into a fearless, first-to-market platform for women’s sexual and reproductive health, normalizing taboo topics, and launching new verticals.  ]]></description>
      <pubDate>Fri, 01 Aug 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4lpRTMXqQzEknk4UlRQbg3/8aa2613f55ebaa09087a2db804513d72/Monica_Cepak-thumbnail-1920x1080.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/entrepreneurship/how-a-teen-turned-his-rare-diagnoses-into-a-rare-movement</guid>
      <title><![CDATA[How a Teen Turned His Rare Diagnoses into a Rare Movement]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/entrepreneurship/how-a-teen-turned-his-rare-diagnoses-into-a-rare-movement</link>
      <description><![CDATA[16-year-old entrepreneur Khartik Uppalapati, co-founder of the RareGen Youth Network, is combining AI innovation and advocacy to reshape how rare diseases are diagnosed and addressed globally.]]></description>
      <pubDate>Tue, 22 Jul 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6vLhz22qUJ7pUqaM99Z2q2/cc23c8194ba7d8da80b028513f105568/Bangkok_UN1.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-a-pcos-diagnosis-fueled-one-founders-mission-to-disrupt-womens-health</guid>
      <title><![CDATA[How a PCOS Diagnosis Fueled One Founder’s Mission to Disrupt Women’s Health]]></title>
      <link>https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-a-pcos-diagnosis-fueled-one-founders-mission-to-disrupt-womens-health</link>
      <description><![CDATA[Ali Chappell, PhD, RD, Co-Founder and CEO of Lilli Health, shares how she transformed her experience with PCOS into a data-driven nutrition and wellness company offering services and app to have “a dietitian in your pocket.”
]]></description>
      <pubDate>Tue, 15 Jul 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/Z9BGn0kH7oZRzXiCimVUT/32a7eaccfc66a52aba9595ef7a76a01c/2025.7_Ali_Chappell__PhD__RD_1920x1080.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/reimagining-pediatric-care-how-one-nonprofit-is-setting-a-new-standard</guid>
      <title><![CDATA[Reimagining Pediatric Care: How One Nonprofit is Setting a New Standard for Health Equity]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/reimagining-pediatric-care-how-one-nonprofit-is-setting-a-new-standard</link>
      <description><![CDATA[Robyn Riseberg, MD, shares how she founded Boston Community Pediatrics as the first nonprofit private pediatric practice to bring integrated healthcare to children in Boston.]]></description>
      <pubDate>Mon, 14 Jul 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5XPRjHtaI7g2ywtDGdIqWz/5a837d1c28f56ff016d3bab8bb7f3b41/Patients_3.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/mentor-lessons-healthcare-entrepreneurs</guid>
      <title><![CDATA[What My Mentor Taught Me: Healthcare Entrepreneurs Share Lessons Learned]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/mentor-lessons-healthcare-entrepreneurs</link>
      <description><![CDATA[Five healthcare entrepreneurs share pivotal mentorship advice that helped them navigate career shifts and overcome scientific setbacks.]]></description>
      <pubDate>Fri, 06 Jun 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5GqWMCu2UasjJTgJab6S5o/b4e1f9a10ed0ab9d98c0c116719d3646/GettyImages-1322811477.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/from-bench-scientist-to-policy-powerhouse-e-cartier-eshams-entrepreneurial</guid>
      <title><![CDATA[From Bench Scientist to Policy Powerhouse: E. Cartier Esham’s Entrepreneurial Pivot]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/from-bench-scientist-to-policy-powerhouse-e-cartier-eshams-entrepreneurial</link>
      <description><![CDATA[After a career championing entrepreneurs and science policy at BIO, E. Cartier Esham, PhD, launched her own firm to help healthcare innovators navigate Washington, DC, and shape the future of medicine]]></description>
      <pubDate>Tue, 06 May 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/tLeA1BjC7YyeCaYA3bWE3/4eda8b693fad8ba9d31f8c14cee79f47/cure_website_headshot_Cartier-Esham.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/founder-stories/how-a-startup-targets-a-deadly-lung-disease</guid>
      <title><![CDATA[How a Startup Targets a Deadly Lung Disease]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/founder-stories/how-a-startup-targets-a-deadly-lung-disease</link>
      <description><![CDATA[Adiutrix Therapeutics is developing a novel targeted therapy for the lung-stiffening disease known as idiopathic pulmonary fibrosis, offering the potential to be safer and more potent than current treatments.]]></description>
      <pubDate>Fri, 02 May 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3UWiOq4n8Q2md051zgZDcC/f7172ec06e916e634ec34585cc9e6d90/Xseed2025_finalist_RSilver.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/metabolic-diseases/founder-stories/novel-biologic-aims-to-stop-kidney-damage-before-it-turns-chronic</guid>
      <title><![CDATA[Novel Biologic Aims to Stop Kidney Damage Before it Turns Chronic]]></title>
      <link>https://wewillcure.com/insights/metabolic-diseases/founder-stories/novel-biologic-aims-to-stop-kidney-damage-before-it-turns-chronic</link>
      <description><![CDATA[Sidereal Therapeutics is developing a potential first-in-class biologic to prevent acute kidney injury from progressing to chronic disease by targeting iron overload at its source.]]></description>
      <pubDate>Fri, 02 May 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/ntKohh25mAhcqvNnQYpwU/01f87a29e366ef540d55234990924d0c/Xseed2025_finalist_MLWarner.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-one-company-targets-dialysis-complications-with-novel-therapy</guid>
      <title><![CDATA[How One Company Targets Dialysis Complications with Novel Therapy]]></title>
      <link>https://wewillcure.com/insights/metabolic-diseases/founder-stories/how-one-company-targets-dialysis-complications-with-novel-therapy</link>
      <description><![CDATA[Vasocure is advancing targeting therapies to prevent arteriovenous graft (AVG) stenosis for patients on kidney dialysis that may also unlock new treatments for atherosclerosis.]]></description>
      <pubDate>Thu, 01 May 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3tue8oL9pAz03KRK0nqABR/8a4bac88b6aa69e1251e777d5d783a67/Xseed2025_finalist_MSalifu_.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/founder-stories/hibernating-bears-heart-failure-therapy</guid>
      <title><![CDATA[From Hibernating Bears to Humans: A New Therapeutic Path for Heart Failure ]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/founder-stories/hibernating-bears-heart-failure-therapy</link>
      <description><![CDATA[GenKardia's technology is a novel compound targeting Titin — a protein linked to heart stiffness — that takes inspiration from a surprising source: hibernating bears.]]></description>
      <pubDate>Wed, 30 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4DmDFCW6m6lLR6LzQtZw3/36d8442000aff5a5098a86eb60e9953b/xseed2025_winner_RNkulikiyinka_1200x675.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/neurological-health/founder-stories/fight-alzheimers-new-approach-amyloid</guid>
      <title><![CDATA[How This Company is Fighting Alzheimer's With a New Approach to Amyloid]]></title>
      <link>https://wewillcure.com/insights/neurological-health/founder-stories/fight-alzheimers-new-approach-amyloid</link>
      <description><![CDATA[XSeed Award finalist Aggregate Biosciences is developing precision diagnostics and therapeutics aiming to transform treatment for Alzheimer’s, type 2 diabetes, and other amyloid-related diseases.]]></description>
      <pubDate>Tue, 29 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/lUPUDVNoITJVB5UcP7eoQ/60261763060f5c0382862bef0b41fb45/Xseed2025_finalist_MKazmi.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/neurological-health/founder-stories/how-sunbird-bio-is-changing-brain-disease-diagnoses</guid>
      <title><![CDATA[How Sunbird Bio is Changing Brain Disease Diagnoses  ]]></title>
      <link>https://wewillcure.com/insights/neurological-health/founder-stories/how-sunbird-bio-is-changing-brain-disease-diagnoses</link>
      <description><![CDATA[Sunbird Bio's platform aims to address a $20 billion global neurology diagnostics market to test for Alzheimer’s, Parkinson’s, ALS and more. ]]></description>
      <pubDate>Tue, 22 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5YVXI3dgeiVlFMYySCEBuq/604f216c754ed0d33675b083df765f1d/GettyImages-1439039971.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/womens-health-ceo-shares-advice-on-raising-funds-be-direct</guid>
      <title><![CDATA[Women’s Health CEO Shares Advice on Raising Funds: Be Direct]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/womens-health-ceo-shares-advice-on-raising-funds-be-direct</link>
      <description><![CDATA[CEO Marissa Fayer draws on her engineering background to lead DeepLook Medical and advises women’s health startups to think big, stay strategic, and seek broader investor support.]]></description>
      <pubDate>Fri, 11 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6z4tZuY45mBiGA3Io03DFq/b52acb925f23871763559b911f81654a/thumbnail_marissa_fayer.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/how-tia-stays-competitive-in-a-crowded-healthcare-landscape</guid>
      <title><![CDATA[How Tia Stays Competitive in a Crowded Healthcare Landscape]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/how-tia-stays-competitive-in-a-crowded-healthcare-landscape</link>
      <description><![CDATA[Tia Health is reshaping women’s healthcare experiences with primary care in-person clinics that offer collaborative, holistic patient-centric approach.]]></description>
      <pubDate>Mon, 07 Apr 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3mVrebC3tggJVdST3WR94b/733dae1259700890de3816bf08cf8e1e/thumbnail_tia_ceo_felicity_yost.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/mahzi-therapeutics-ceos-advice-for-biotech-female-founders</guid>
      <title><![CDATA[Mahzi Therapeutics CEO's Advice for Biotech Female Founders]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/mahzi-therapeutics-ceos-advice-for-biotech-female-founders</link>
      <description><![CDATA[Yael Weiss, MD, PhD, founder and CEO of Mahzi Therapeutics, shares her path to biotech leadership, offering insights on navigating the male-dominated industry and championing patient-centered innovation.]]></description>
      <pubDate>Tue, 25 Mar 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3RSNfNcZDLkkGFdC3Vdpmu/984d8d20b57a26b457c4778b67cf07c6/thumbnail_website_yael_weiss.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/how-an-unconventional-ceo-is-reimagining-drug-discovery</guid>
      <title><![CDATA[How an Unconventional CEO is Reimagining Drug Discovery]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/how-an-unconventional-ceo-is-reimagining-drug-discovery</link>
      <description><![CDATA[Montai Therapeutics, led by former Google executive Margo Georgiadis, is using AI to transform drug discovery by identifying and optimizing natural compounds, expanding access to small-molecule treatments for chronic diseases.]]></description>
      <pubDate>Wed, 19 Mar 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3MY1jDpN87z0BLbjfEZMqS/38e740238b60e7b620baa392c001a87b/thumbnail_website_margo_georgiadis.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/funding-and-models/lime-therapeutics-pioneers-therapies-targeting-lipid-biology</guid>
      <title><![CDATA[Lime Therapeutics Pioneers Therapies Targeting Lipid Biology]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/funding-and-models/lime-therapeutics-pioneers-therapies-targeting-lipid-biology</link>
      <description><![CDATA[Lime Therapeutics is pioneering lipid-focused drug discovery, hunting for dysfunctions and related targets for drug discovery that could lead to new therapies for cancers, cardiometabolic diseases, lysosomal storage diseases or neurodegenerative disorders.
]]></description>
      <pubDate>Mon, 17 Mar 2025 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2QM1u24KJvbWPJ1tKB6XaW/e731fa5a8cc9d46ff54fb45eb2a9663e/thumbnail_cell_membrane_structure_GTY1909959339.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/celmatix-therapeutics-seeks-to-counter-ovarian-aging</guid>
      <title><![CDATA[How Celmatix Therapeutics Seeks to Counter Ovarian Aging]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/celmatix-therapeutics-seeks-to-counter-ovarian-aging</link>
      <description><![CDATA[Celmatix Therapeutics is developing a novel therapy to extend the lifespan of the ovary, potentially reducing the risk of such disorders as heart disease, autoimmune diseases, osteoporosis and neurocognitive decline later in life.]]></description>
      <pubDate>Tue, 11 Mar 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7J0PrxiX7UnPYkoI9K0x3f/51532fc41058578b7c8c04526bef08cc/thumbnail_OBGYN_ovaries_consultation_GTY1401773686.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/aspira-womens-health-developing-endometriosis-test</guid>
      <title><![CDATA[Aspira Women's Health Developing Endometriosis Test]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/aspira-womens-health-developing-endometriosis-test</link>
      <description><![CDATA[Aspira Women's Health is developing an AI-enabled blood test to diagnose endometriosis without surgery.]]></description>
      <pubDate>Thu, 20 Feb 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/10uUDvlfp3g8Hs1DAcYFBI/3c22f6c88f74084037fa4e2885f496a5/thumb_digital_lab_GTY1444835485.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/infectious-disease/founder-stories/how-chandrabali-ghose-drives-therapeutic-innovation</guid>
      <title><![CDATA[How Chandrabali Ghose Drives Therapeutic Innovation]]></title>
      <link>https://wewillcure.com/insights/infectious-disease/founder-stories/how-chandrabali-ghose-drives-therapeutic-innovation</link>
      <description><![CDATA[XSeed Award winner Chandrabali Ghose, PhD, a pioneer of novel antibiotic research, now innovates Cystic Fibrosis solutions and offers funding insights for startups.]]></description>
      <pubDate>Fri, 24 Jan 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/70MGmeYqVv39GfSqIPi5EN/19ee1f58c26388a58f8ccf6a8d8fc440/xseed-past-winner-chandrabali-ghose.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/revolutionizing-menopause-care-elektra-health-leads-the-way</guid>
      <title><![CDATA[Revolutionizing Menopause Care: Elektra Health Leads the Way]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/revolutionizing-menopause-care-elektra-health-leads-the-way</link>
      <description><![CDATA[Elektra Health is transforming menopause care with personalized, evidence-based virtual support and education, helping women lead healthier, more productive lives.]]></description>
      <pubDate>Tue, 07 Jan 2025 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3IYKOgm0FmFFeKOaDLhv2U/f7d9162b527d8d171347af757128f6c0/thumbnail-tuesday-talk-alessandra_henderson.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/medtech/founder-stories/bonnie-anderson-innovator-of-genomic-diagnostics</guid>
      <title><![CDATA[Bonnie Anderson: Innovator of Genomic Diagnostics]]></title>
      <link>https://wewillcure.com/insights/medtech/founder-stories/bonnie-anderson-innovator-of-genomic-diagnostics</link>
      <description><![CDATA[With a proven track record of driving innovation, scaling companies, and navigating complex regulatory landscapes, Anderson continues to lead the charge in making personalized diagnostics a reality for people worldwide.]]></description>
      <pubDate>Wed, 18 Dec 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4fr1iPozX2NH5sERBdGzjq/ba7e25d4f33b5d6d4abac7bd89c7499f/image-bonnie-anderson.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/4-tips-for-biotech-startups-panacea-ventures-james-huang</guid>
      <title><![CDATA[4 Tips for Biotech Startups: Panacea Venture's James Huang]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/4-tips-for-biotech-startups-panacea-ventures-james-huang</link>
      <description><![CDATA[James Huang, MBA, of Panacea Venture offers advice about what's essential for biotech entrepreneurs to know when preparing to launch a startup.]]></description>
      <pubDate>Fri, 13 Dec 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3BmxHwAx3xHIPhvmP00IGn/1d226f6e8ec66d66f330bac5cb054f63/image_james-huang-panacea-ventures.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/shadow-of-chernobyl-drives-innovation-in-womens-cancer-treatment</guid>
      <title><![CDATA[Shadow of Chernobyl Drives Innovation in Women's Cancer Treatment]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/shadow-of-chernobyl-drives-innovation-in-womens-cancer-treatment</link>
      <description><![CDATA[Stella Vnook, PhD, is a serial entrepreneur who brings deep scientific and business expertise to cancer drug development]]></description>
      <pubDate>Tue, 03 Dec 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5ijMpos6Jbj3eHuOGlynmO/354b5abad08bbfa9d1e5ab2e632e843a/image-stella-vnook.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/oncology/founder-stories/kristen-dahlgrens-journey-to-cancer-vaccine-advocate</guid>
      <title><![CDATA[Kristen Dahlgren’s Journey to Cancer Vaccine Advocate]]></title>
      <link>https://wewillcure.com/insights/oncology/founder-stories/kristen-dahlgrens-journey-to-cancer-vaccine-advocate</link>
      <description><![CDATA[Award-winning journalist and cancer survivor creates Cancer Vaccine Coalition]]></description>
      <pubDate>Thu, 21 Nov 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7b0odcTR3xPqVFiHx7XJlM/57cb42c2d83df11bff66de6a6a4e7d23/thumbnail_krysten_dalhgren_thames.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/care-delivery/founder-stories/stephen-klasko-on-disrupting-healthcare-systems-to-improve</guid>
      <title><![CDATA[Stephen Klasko on Disrupting Healthcare Systems to Improve ]]></title>
      <link>https://wewillcure.com/insights/care-delivery/founder-stories/stephen-klasko-on-disrupting-healthcare-systems-to-improve</link>
      <description><![CDATA[Stephen K. Klasko, MD, MBA, has spent most of his career as a protagonist of transformation within large healthcare systems .]]></description>
      <pubDate>Wed, 13 Nov 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2eFlzVDQrsHZXvNnFtixsn/ba009da8f00778cfe8233a4c9a194009/thumbnail_steve_klasko_headshot.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/neurological-health/founder-stories/new-approach-for-neurodegenerative-diseases-like-ms-and-als</guid>
      <title><![CDATA[New Approach for Neurodegenerative Diseases like MS and ALS  ]]></title>
      <link>https://wewillcure.com/insights/neurological-health/founder-stories/new-approach-for-neurodegenerative-diseases-like-ms-and-als</link>
      <description><![CDATA[Working with his Einstein colleagues, Nicholas Sibinga, MD, earned a 2022 XSeed Award for identifying a protein pathway with potential to help prevent devastating neurodegenerative diseases including multiple sclerosis and ALS.]]></description>
      <pubDate>Fri, 01 Nov 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/23ZKs8UU4yQUvJUnTrZleD/8033f61988ecb22818525ec1aadecc23/xseed-past-winner-nicholas-sibinga.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/five-tips-for-entrepreneurs-from-alex-zhavoronkov-phd-ceo-of-insilico</guid>
      <title><![CDATA[Five Tips for Entrepreneurs from Alex Zhavoronkov, PhD, CEO of Insilico Medicine]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/five-tips-for-entrepreneurs-from-alex-zhavoronkov-phd-ceo-of-insilico</link>
      <description><![CDATA[Alex Zhavoronkov, PhD, CEO of Insilico Medicine, — one of the world's top generative AI drug discovery companies,  shares his top five tips for biotech startup entrepreneurs on how to maximize success.]]></description>
      <pubDate>Wed, 02 Oct 2024 04:05:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/B4bokUInCUmar6QShBfsP/be44957ab93b0c6d02c10fe21e72ea13/thumbnail_alex_zhavoronkov_green_background.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founding-and-scaling/from-friends-to-founders-on-a-mission-to-combat-kidney-disease</guid>
      <title><![CDATA[From Friends to Founders: On a Mission to Combat Kidney Disease]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founding-and-scaling/from-friends-to-founders-on-a-mission-to-combat-kidney-disease</link>
      <description><![CDATA[With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.]]></description>
      <pubDate>Fri, 27 Sep 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5RucWfuV6vpwrn7vX9O1Ea/228558553a9ca67a5114f47bb5e49067/xseed-past-winner-rohini_kalvakuntla.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and</guid>
      <title><![CDATA[Lexeo Therapeutics: Revolutionizing Genetic Medicine for Cardiovascular and Neurodegenerative Diseases ]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/lexeo-therapeutics-revolutionizing-genetic-medicine-for-cardiovascular-and</link>
      <description><![CDATA[Lexeo Therapeutics is developing pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.]]></description>
      <pubDate>Wed, 18 Sep 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/26nhPSDw7uhz9OuNcJb70h/89d35896042bac4507904fc2cfe0ecda/241809_genetic_therapy_development_thumbnail_1920x1080.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/funding-and-models/one-unrestricted-grant-yields-multiple-opportunities-for-health</guid>
      <title><![CDATA[One Unrestricted Grant Yields Multiple Opportunities for Health]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/funding-and-models/one-unrestricted-grant-yields-multiple-opportunities-for-health</link>
      <description><![CDATA[Neuropharmacology and drug delivery expert Ashiwel Undieh, PhD, shares how his 2021 XSeed Award accelerated and enables his research. ]]></description>
      <pubDate>Fri, 13 Sep 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3lmkoWOn7cuRn3JGEFXM4/37ee0bdd935594c9290be2a471d9b811/thumbnail-ashiwel-undieh.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article_spotlight-on-christine-brideau-drug-discovery-scientist-and</guid>
      <title><![CDATA[Spotlight on Christine Brideau, Drug Discovery Scientist and XSeed Award Judge]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article_spotlight-on-christine-brideau-drug-discovery-scientist-and</link>
      <description><![CDATA[3DC drug discovery scientist Christine Brideau's translational science expertise helps advance basic research to clinical studies to successful medicines. She also helps pick XSeed Award winners developing their own new drugs. ]]></description>
      <pubDate>Tue, 10 Sep 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/78b9JQTCo1bqQtaFcjjeNc/bca0e6eb11ecfb777bd1da26c2c93a24/Christine_Brideau_thumbnail_green_1200x675.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/founder-stories/insights_article-xseed-award-finalist-dori-thomas-karyat-phd-founder-and-ceo</guid>
      <title><![CDATA[Spotlight on XSeed Award Finalist: Dori Thomas-Karyat, PhD, Founder and CEO of Synthis Therapeutics ]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/founder-stories/insights_article-xseed-award-finalist-dori-thomas-karyat-phd-founder-and-ceo</link>
      <description><![CDATA[Dori Thomas-Karyat, PhD, is developing a potential first-in-class treatment for idiopathic pulmonary fibrosis — a progressive debilitating lung disease with limited therapeutic options.]]></description>
      <pubDate>Wed, 28 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/43S69P3ZmFIxCk4WJRqp6E/4a55d676f8244d56de37e44832e967aa/xseed-past-winner-dori-thomas-karyat_.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/oncology/founder-stories/insights_article-spotlight-on-xseed-award-finalist-jahanara-ali-phd-chief</guid>
      <title><![CDATA[Spotlight on XSeed Award Finalist: Jahanara Ali, PhD, Chief Business Officer, NomoCan Pharmaceuticals]]></title>
      <link>https://wewillcure.com/insights/oncology/founder-stories/insights_article-spotlight-on-xseed-award-finalist-jahanara-ali-phd-chief</link>
      <description><![CDATA[Jahanara Ali, PhD, of NomoCan Pharmaceuticals, is developing a first-in-class monoclonal antibody to treat patients with the blood cancer acute myeloid leukemia (AML), but it may have applications for solid tumor cancers.]]></description>
      <pubDate>Fri, 23 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4KmrEdUujY8A6oMuCODIvb/9f0e86023380199544fe8018cd145323/thumbnail-xseed-2024-jahanara-ali.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/oncology/founder-stories/insights_article-spotlight-on-xseed-award-finalist-paraskevi-giannakakou-phd</guid>
      <title><![CDATA[Spotlight on XSeed Award Finalist: Paraskevi Giannakakou, PhD, Co-Founder, ARMA BIO]]></title>
      <link>https://wewillcure.com/insights/oncology/founder-stories/insights_article-spotlight-on-xseed-award-finalist-paraskevi-giannakakou-phd</link>
      <description><![CDATA[Paraskevi Giannakakou, PhD, is developing a first-in-class small molecule that may defeat the resistance many patients with advanced prostate cancer develop to standard-of-care anticancer drugs.]]></description>
      <pubDate>Fri, 16 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6cMdsVkNUBldMiuJB6JKQd/a12201c326c2a69ff8ea850756c98bd1/thumbnail-xseed-2024-evi-giannakakou.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-xseed-award-finalist-daria-lizneva</guid>
      <title><![CDATA[Spotlight on XSeed Award Finalist: Daria Lizneva, MD, PhD, Mount Sinai]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-xseed-award-finalist-daria-lizneva</link>
      <description><![CDATA[XSeed Award Finalist Daria Lizneva, MD, PhD, is developing a potential first-in-class small molecule for the long-term management of obesity.]]></description>
      <pubDate>Fri, 09 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/58X7VE71BM8trIz6xqVySW/c04d874251c953e9f3e203a15f4524b2/thumbnail_daria_lizneva_xseed_winner_2024.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/care-delivery/founder-stories/insights-article_delivering-healthcare-in-places-of-trust-the-oben-health</guid>
      <title><![CDATA[Delivering Healthcare in Places of Trust: The Oben Health Barbershop Model]]></title>
      <link>https://wewillcure.com/insights/care-delivery/founder-stories/insights-article_delivering-healthcare-in-places-of-trust-the-oben-health</link>
      <description><![CDATA[Oben Health is improving care access using AI to facilitate screenings, education and connections to treatment in nontraditional spaces like barbershops, havens of support especially in communities of color.

]]></description>
      <pubDate>Wed, 07 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4qecoefCCjfjRVQYSOE8mv/d9a83d964fabb1b59598ce1766e01cce/thumbnail-oben-health-barbershop-model.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article-spotlight-on-xseed-award-finalist-carol-troy-md-phd</guid>
      <title><![CDATA[Spotlight on XSeed Award Finalist:  Carol Troy, MD, PhD, Columbia University Neurologist ]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article-spotlight-on-xseed-award-finalist-carol-troy-md-phd</link>
      <description><![CDATA[XSeed Award Finalist Carol M. Troy, MD, PhD, is developing a novel eye drop medication that could become the first noninvasive treatment for retinal vascular occlusion.]]></description>
      <pubDate>Fri, 02 Aug 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7zM1AYxOn6E5QlgKS2nPhT/c1e8165828848cd8e2308c31246f8bbc/thumbnail_xseed2024_carol_troy_lab_photo.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/insights_article-helaina-transforming-nutrition-with-bioactive-proteins</guid>
      <title><![CDATA[Helaina: Transforming Nutrition with Bioactive Proteins  ]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/insights_article-helaina-transforming-nutrition-with-bioactive-proteins</link>
      <description><![CDATA[Leveraging her background ​as a food scientist, ​Laura Katz, MA, ​founded​ and helms Helaina, a company using its​ proprietary  platform to recreate the ​bioactive proteins found in​ human colostrum and​ milk​ to improve health for people of all ages​. ]]></description>
      <pubDate>Mon, 22 Jul 2024 04:01:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3YFg9SyAR1FhFAWuwZUmc/f8cad68505f427931a3231c1bcb06ef7/events_thumbnail_tuesday_talks_laura_katz.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article-sheba-arcs-eyal-zimlichman-driving-systemic-change-in</guid>
      <title><![CDATA[Sheba ARC’s Eyal Zimlichman Driving Systemic Change in Healthcare ]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/insights_article-sheba-arcs-eyal-zimlichman-driving-systemic-change-in</link>
      <description><![CDATA[Eyal Zimlichman, MD, founder of the ARC Innovation Center at Sheba Medical Center, the Middle East’s largest healthcare system, brings players in digital medicine together with external partners to accelerate change in healthcare on a global scale.]]></description>
      <pubDate>Mon, 15 Jul 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3Zsb0Mu4dvbBA3GTDSF9ME/1e4f64e8a461bb19d7187c2d4b16a21f/thumbnail_eyal_zimlichman_july2024.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/can-understanding-the-vaginal-microbiome-improve-womens-health</guid>
      <title><![CDATA[Can Understanding the Vaginal Microbiome Improve Women's Health?]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/can-understanding-the-vaginal-microbiome-improve-womens-health</link>
      <description><![CDATA[The startup Evvy is advancing the science of the vaginal microbiome to yield more precise diagnostics that could improve women’s health and shaping a market that has significant potential.]]></description>
      <pubDate>Mon, 24 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4DnQsyrrH6Vsn8KfqSapcI/09c45b8526c03c2ef97f69b5ff866826/thumbnail_How_the_Vaginal_Microbiome_May_Improve_Women-s_Healthcare.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-the-science-of-leadership-5-insights-from-evommune-ceo</guid>
      <title><![CDATA[The Science of Leadership: 5 Insights from Evommune CEO Luis Peña]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-the-science-of-leadership-5-insights-from-evommune-ceo</link>
      <description><![CDATA[Evommune founder Luis Peña expertise spans a spectrum of life science companies. He co-founded Dermira, was Senior Vice President of Portfolio Planning and Management at Stiefel, and held key roles at Connetics, Theravance and Genentech.]]></description>
      <pubDate>Thu, 06 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3aDy2J52EV7GlXo8ThQA7P/1f3853ab3c1eb80b494154c847d41ac9/Business_discussion.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/investment/founder-stories/mvp-insights_article-dysons-wellville-makes-long-term-investment-in</guid>
      <title><![CDATA[Dyson's Wellville Makes Long Term Investment in Wellbeing]]></title>
      <link>https://wewillcure.com/insights/investment/founder-stories/mvp-insights_article-dysons-wellville-makes-long-term-investment-in</link>
      <description><![CDATA[Thinking long term about health and well-being agendas set by residents is the foundation for Wellville, the national equitable wellbeing project founded by Esther Dyson, author, angel investor and tech entrepreneur.]]></description>
      <pubDate>Thu, 06 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7a9hO06ec5SRTPmhQDJxeL/c51b569a0cf1f09f97e3b7ea9d4fb905/Esther_Dyson.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founding-and-scaling/mvp-insights_article-haseltines-five-take-home-messages-for-biotechnology</guid>
      <title><![CDATA[Haseltine's Five Take-Home Messages for Biotechnology Success]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founding-and-scaling/mvp-insights_article-haseltines-five-take-home-messages-for-biotechnology</link>
      <description><![CDATA[A pioneer in biotechnology and prolific author, William Haseltine, PhD, has achievements including sequencing the human genome, milestone work in cancer, HIV/AIDS, genomics and COVID-19, founding more than a dozen biotech companies and reducing health disparities.]]></description>
      <pubDate>Wed, 05 Jun 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/77qtGtjN4K4M2V6r7u43f0/9a872498afe5c8fc0db4ffc5f7407c18/headshot_bill_haseltine_article_background.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/clinical-trials/founder-stories/mvp-insights_article-a-toolkit-for-streamlining-biotech-clinical-trials</guid>
      <title><![CDATA[A Toolkit for Streamlining Biotech Clinical Trials]]></title>
      <link>https://wewillcure.com/insights/clinical-trials/founder-stories/mvp-insights_article-a-toolkit-for-streamlining-biotech-clinical-trials</link>
      <description><![CDATA[Vishal Mehta, MSHS, Founder and CEO of Ubuntu Research, developed a subscription-based model to create streamlined, cost-effective clinical trials, a potential resource for smaller life science companies.]]></description>
      <pubDate>Wed, 05 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4eA1WGnlWXlfxibd3oDj5X/934d1acb82bba65913c14b9a06519ec6/Pipetting.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-global-perspective-top-3-leadership-lessons-from-lexeo</guid>
      <title><![CDATA[Global Perspective: Top 3 Leadership Lessons from Lexeo CEO Nolan Townsend]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-global-perspective-top-3-leadership-lessons-from-lexeo</link>
      <description><![CDATA[Before he became CEO of Lexeo Therapeutics, R. Nolan Townsend, MBA, worked across Pfizer, in Finance, Corporate Strategy, Operations and Marketing, and Rare Disease in North America, Asia, Africa/Middle East and Europe. 
]]></description>
      <pubDate>Wed, 05 Jun 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/7CvGzhkNhRW3n5uZBaaq9l/acaf91b91985a324f6e8fc04dc918bc0/Female_CEO.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/mvp-article-insilico-talks-ai</guid>
      <title><![CDATA[From Clinic to Climate: Insilico’s Alex Zhavoronkov Talks AI]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/mvp-article-insilico-talks-ai</link>
      <description><![CDATA[Biotech Insilico Medicine aims to transform drug discovery and development using generative AI. that discovers novel targets, generates new molecules, and predicts clinical trial success.
]]></description>
      <pubDate>Fri, 31 May 2024 04:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/62YbXAOwdFqEv0KQZfdtcG/5d893317865a87b46ec983a2c549ebf9/Computer-Screens-with-DNA.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-why-female-diversity-is-a-must-have-for-biopharma</guid>
      <title><![CDATA[Why Female Diversity is a “Must-Have” for BioPharma]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/mvp-insights_article-why-female-diversity-is-a-must-have-for-biopharma</link>
      <description><![CDATA[Despite decades of efforts to increase their inclusion, women remain a minority in STEM fields, including drug discovery and AI for health.]]></description>
      <pubDate>Tue, 09 Apr 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/5tPmH32wSAjzChQRn1wZn2/01f76e82ef554907296c38050695df9c/Exploring_Culture___Diversity_in_BioPharma_16_9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/five-winners-of-cure-xchange-challenge</guid>
      <title><![CDATA[Five Winners of Cure Xchange Challenge: Health AI For Good Announced]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/five-winners-of-cure-xchange-challenge</link>
      <description><![CDATA[Five startup companies have won the inaugural Cure Xchange Challenge: Health AI for Good. Allagi.ai, BioCurie, Deepecho, Every Cure and Oben Health will receive one-year residencies at Cure’s innovation campus in New York City along with unrestricted seed grants, mentoring, in-kind resources and support services from Cure’s partners, including Amazon Web Services, ThermoFisher and NVIDIA.]]></description>
      <pubDate>Fri, 23 Feb 2024 19:00:00 GMT</pubDate>
      <media:content url="https://www.youtube.com/watch?v=D7FDpUE1a-k" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/care-delivery/founder-stories/spotlight-on-collogh-cares-co-founder-collins-oghor-md-mba-mph</guid>
      <title><![CDATA[Spotlight On: Collogh Cares Co-founder Collins Oghor, MD, MBA, MPH]]></title>
      <link>https://wewillcure.com/insights/care-delivery/founder-stories/spotlight-on-collogh-cares-co-founder-collins-oghor-md-mba-mph</link>
      <description><![CDATA[When he was a little boy, Collins “Collogh” Oghor lost his aunt to kidney failure, and now, having earned an MD, MBA, and MPH, he has developed an AI solution to help healthcare providers battle this devastating — and preventable — disease.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/1u69mUkfA2sJscpIufH9X2/56c4cad7a8965ce21468608dda68dbe0/Collogh-Cares-Logo.jpg" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/grant-mitchell-every-cure</guid>
      <title><![CDATA[Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/grant-mitchell-every-cure</link>
      <description><![CDATA[Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  ]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2R4BS8D097mOlrwIxhnVPI/14d434ce5bb076ad28fb323e69436fc1/CURExChange_Challenge-186_Large.jpeg" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-kwamane-liddell-jd-mha-bsn-co-founder-thrivelink-formerly</guid>
      <title><![CDATA[Spotlight On: Kwamane Liddell, JD, MHA, Co-founder ThriveLink (formerly Nutrible) ]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-kwamane-liddell-jd-mha-bsn-co-founder-thrivelink-formerly</link>
      <description><![CDATA[As an ER nurse, Kwamane Liddell, JD, MHA, BSN, encountered many low-income families whose language barriers kept them from taking advantage of nutritious food assistance programs. He realized AI could help these families successfully access not only nutrition but also medicine, housing, and even health insurance.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2exDGFCH7NCVvfay2ccU3S/965dfea812255786d6ca36402f8eb15d/ThriveLink_LG_Logo.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/spotlight-on-irene-rombel-phd-mba-co-founder-biocurie</guid>
      <title><![CDATA[Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie]]></title>
      <link>https://wewillcure.com/insights/cell-and-gene-therapeutics/founder-stories/spotlight-on-irene-rombel-phd-mba-co-founder-biocurie</link>
      <description><![CDATA[With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/29b61KHxbazj7cBkEqXcU1/f1e07fca8a406ce81d90a660c3d24656/Biocurie_1920x1080.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-oatmeal-health-co-founder-jonathan-govette</guid>
      <title><![CDATA[Spotlight On: Oatmeal Health Co-founder Jonathan Govette]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-oatmeal-health-co-founder-jonathan-govette</link>
      <description><![CDATA[Driven to help people in marginalized communities get the healthcare they deserve, Jonathan Govette and his co-founders developed an AI solution for identifying people at high risk for lung cancer, so they can get treated early — saving both money and lives.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/4OaxPlt06IB23sfwgHbGYC/4c42daf8f0b553cefc81995a53e7784d/Oatmeal_Health_1920x1080.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-saad-slimani-md-ms-co-founder-of-deepecho</guid>
      <title><![CDATA[Spotlight On: Saad Slimani, MD, MS,  Co-founder of Deepecho]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-saad-slimani-md-ms-co-founder-of-deepecho</link>
      <description><![CDATA[As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.]]></description>
      <pubDate>Tue, 20 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2CnpiKMGUJs7KqRSYluPgz/e230df801028255443810d7d35e9d593/Deepecho_1920x1080.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-alex-gavryushkin-founder-of-allagi-ai</guid>
      <title><![CDATA[Spotlight On: Alex Gavryushkin, Founder of Allagi.ai]]></title>
      <link>https://wewillcure.com/insights/entrepreneurship/founder-stories/spotlight-on-alex-gavryushkin-founder-of-allagi-ai</link>
      <description><![CDATA[Through his company Allagi.ai, Alex Gavryushkin, PhD, is using AI to streamline a time-consuming process for oncologists, allowing them to devise more effective treatment plans for patients, including those with rare and hard-to-treat cancers.]]></description>
      <pubDate>Tue, 20 Feb 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/17uO0B9f4oI4fBrd2XnJYw/0e8bab1e66c62131b08f896d278da2c4/allagi_logo_white.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-robhy-bustami-co-founder-of-bioticsai</guid>
      <title><![CDATA[Spotlight On: Robhy Bustami, Co-founder of BioticsAI]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-robhy-bustami-co-founder-of-bioticsai</link>
      <description><![CDATA[AI engineer Robhy Bustami grew up in a family of obstetricians. His knowledge of the challenges around access to quality maternal medicine led him to develop an ultrasound technology solution poised to improve the health of families in underserved communities worldwide.]]></description>
      <pubDate>Mon, 19 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/6Fo0F2W221k5i1pZ8FoFp2/99b181c6d40e4ee93e26ea2bc14d84b0/Biotics.ai_logo.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-peter-njongwe-co-founder-of-oben-health</guid>
      <title><![CDATA[Spotlight On: Peter Njongwe, Co-founder of Oben Health ]]></title>
      <link>https://wewillcure.com/insights/ai-and-machine-learning/founder-stories/spotlight-on-peter-njongwe-co-founder-of-oben-health</link>
      <description><![CDATA[After the sudden death of his older brother from hypertension, Peter Njongwe launched a company that marries cutting-edge AI technology with friendly neighborhood barbershops. It’s an innovative approach to getting hesitant populations to embrace the healthcare they need.]]></description>
      <pubDate>Mon, 19 Feb 2024 22:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/66tMBo8OBa5AG4FX4V8r2p/0f1918f6deaf2226c03a2e3c27883900/Oben_Health_1920x1080.png" medium="image" />
      <category>Xchange Story</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/womens-health/founder-stories/mvp-insights_article-how-a-startup-is-revolutionizing-maternal-healthcare</guid>
      <title><![CDATA[How a Startup Is Revolutionizing Maternal Healthcare]]></title>
      <link>https://wewillcure.com/insights/womens-health/founder-stories/mvp-insights_article-how-a-startup-is-revolutionizing-maternal-healthcare</link>
      <description><![CDATA[Adrianne Nickerson, the co-founder and CEO of Oula, a maternity care clinic, is taking a revolutionary approach to prenatal care, childbirth, and postpartum support. ]]></description>
      <pubDate>Mon, 19 Feb 2024 05:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/3XDbmxP6tk2C9QKkZLR15N/9a0d7efefc6bb9d991dbbf9ef8050a1b/How_a_Startup_Is_Revolutionizing_Maternal_Healthcare_16_9.jpg" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/metabolic-diseases/founder-stories/a-bionic-pancreas-transforms-care-for-people-with-type-1-diabetes</guid>
      <title><![CDATA[Bionic Pancreas Transforms Care for People with Type 1 Diabetes]]></title>
      <link>https://wewillcure.com/insights/metabolic-diseases/founder-stories/a-bionic-pancreas-transforms-care-for-people-with-type-1-diabetes</link>
      <description><![CDATA[Scientific innovations can come from our most personal experiences. For Ed Damiano, PhD, the co-founder of Beta Bionics, his transformational invention began with his son’s diagnosis of type 1 diabetes and an unwavering determination to find a better way to manage the condition.]]></description>
      <pubDate>Thu, 26 Oct 2023 08:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/UB0ZDQgQgf0Yo0IUEYG0Y/9799ead6abc79c79d8034e9f951d237b/Cure_image_-_edited_219_-_bionic_pancreas.png" medium="image" />
      <category>Article</category>
    </item>
<item>
      <guid>https://wewillcure.com/insights/rare-diseases/entrepreneurship/starting-a-revolution-in-treating-rare-diseases</guid>
      <title><![CDATA[Starting a Revolution in Treating Rare Diseases]]></title>
      <link>https://wewillcure.com/insights/rare-diseases/entrepreneurship/starting-a-revolution-in-treating-rare-diseases</link>
      <description><![CDATA[Developing therapies for patients with rare diseases: a career in the Orphan Drug Revolution by Jim Geraghty, JD, MS.]]></description>
      <pubDate>Thu, 12 Oct 2023 08:00:00 GMT</pubDate>
      <media:content url="https://images.ctfassets.net/ou0qvg08mzx4/2iby0AHtQPAFT7p6uT9hbg/8ef2db4d0e20c0b7a3e966ba5f58a2d6/searching_key_genetics_16_9.jpg" medium="image" />
      <category>Article</category>
    </item>
  </channel>
</rss>